Botulinum toxin type A

Abstract

‘Poison can be employed as a means for destruction of life or as a treatment for the sick’ . Such is the case with botulinum toxin type A, said Dr Roger Aoki from Allergan Inc., US, speaking at the 4th Congress of the European Federation of Neurological Societies [ Lisbon, Portugal; September 1999 ]. Allergan’s botulinum toxin type A purified neurotoxin complex [‘BOTOX’] provides a particularly effective approach to the localised treatment of disorders associated with muscle overactivity, with neglible adverse effects. Some of the most recent data on the use of botulinum toxin type A in such indications were discussed at the congress.